Free Trial
→ INSANE DRONE FOOTAGE (From Paradigm Press) (Ad)tc pixel Free FENC Stock Alerts

Adherex Technologies (FENC) Financials

Adherex Technologies logo
$10.18 -0.54 (-5.04%)
Closing price 10/13/2026 04:00 PM Eastern
Extended Trading
$10.18 +0.01 (+0.05%)
As of 05:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Adherex Technologies

Annual Income Statements for Adherex Technologies

This table shows Adherex Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Consolidated Net Income / (Loss)		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Net Income / (Loss) Continuing Operations		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Total Pre-Tax Income 		-0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.07 -9.64
Total Operating Income		 -1.89 -2.87 -6.95 -10 -13 -18 -17 -23 -13 2.57 -6.28
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.17 0.00 1.45 20 44 41
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.17 0.00 1.54 21 48 45
Operating Revenue		 0.00 0.00 0.00 0.00 0.00 0.17 0.00 1.54 21 48 45
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.09 1.26 3.18 3.76
Operating Cost of Revenue		 - - - - - - 0.00 0.09 1.26 3.18 3.76
Total Operating Expenses		 1.89 2.87 6.95 10 13 18 17 24 33 42 47
Selling, General & Admin Expense		 1.63 2.40 5.02 5.40 7.40 13 12 18 21 23 28
Marketing Expense		 - - - - - - 0.00 2.79 12 18 19
Research & Development Expense		 0.26 0.47 1.94 5.01 5.61 5.11 4.98 3.53 0.06 0.31 0.25
Total Other Income / (Expense), net		 1.23 0.08 -0.10 0.52 0.23 -0.22 -0.12 -0.94 -3.27 -2.64 -3.35
Interest Expense		 - - - - - 0.41 0.14 0.93 3.68 4.16 4.17
Interest & Investment Income		 0.00 0.01 0.05 0.35 0.32 0.09 0.05 - 0.44 1.68 0.79
Other Income / (Expense), net		 1.23 0.07 -0.14 0.17 -0.08 0.10 -0.04 -0.01 -0.03 -0.16 0.03
Income Tax Expense		 - - - - - - - - 0.00 0.37 0.11
Basic Earnings per Share		 ($0.06) ($0.22) ($0.47) ($0.52) ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Weighted Average Basic Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.28M 26.57M 27.29M 28.58M
Diluted Earnings per Share		 ($0.06) ($0.22) ($0.47) ($0.52) ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Weighted Average Diluted Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.28M 26.57M 27.29M 28.58M
Weighted Average Basic & Diluted Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.41M 27.10M 27.59M 34.48M

Quarterly Income Statements for Adherex Technologies

This table shows Adherex Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20 1.97
Consolidated Net Income / (Loss)		 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20 1.97
Net Income / (Loss) Continuing Operations		 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20 1.97
Total Pre-Tax Income 		-2.68 13 -5.55 -5.74 -1.62 0.00 -3.15 -0.64 -4.68 0.00 2.02
Total Operating Income		 -1.82 14 -5.04 -5.20 -0.93 -0.81 -2.73 -0.19 -2.55 -0.12 1.74
Total Gross Profit		 9.05 25 6.65 5.62 7.26 8.38 8.69 12 12 15 17
Total Revenue		 9.74 25 7.26 6.97 7.93 8.75 9.65 12 14 15 18
Operating Revenue		 9.74 25 7.26 6.97 7.93 8.75 9.65 12 14 15 18
Total Cost of Revenue		 0.69 0.55 0.61 1.36 0.67 0.37 0.97 0.66 1.76 0.57 0.72
Operating Cost of Revenue		 0.69 0.55 0.61 1.36 0.67 0.37 0.97 0.66 1.76 0.57 0.72
Total Operating Expenses		 11 11 12 11 8.19 9.19 11 12 15 15 15
Selling, General & Admin Expense		 6.97 5.87 6.86 6.12 4.20 5.87 6.53 6.75 8.44 3.19 4.64
Marketing Expense		 3.87 5.21 4.67 4.60 3.94 3.23 4.78 5.21 6.11 11 11
Research & Development Expense		 0.03 0.00 0.16 0.10 0.05 0.09 0.11 0.03 0.02 0.05 0.12
Total Other Income / (Expense), net		 -0.86 -0.91 -0.51 -0.53 -0.69 -0.36 -0.42 -0.45 -2.13 0.32 0.28
Interest Expense		 1.21 1.05 1.07 1.05 1.76 0.61 0.61 0.60 2.36 0.01 0.00
Interest & Investment Income		 - 0.20 0.57 0.52 - 0.24 0.17 0.15 0.23 0.34 0.29
Other Income / (Expense), net		 0.01 -0.05 -0.02 -0.00 -0.09 0.01 0.02 -0.00 0.00 -0.01 -0.01
Income Tax Expense		 - - - - - - 0.00 - - - 0.04
Basic Earnings per Share		 ($0.09) $0.47 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01 $0.06
Weighted Average Basic Shares Outstanding		 26.57M 27.05M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 34.34M 34.55M
Diluted Earnings per Share		 ($0.09) $0.41 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01 $0.05
Weighted Average Diluted Shares Outstanding		 26.57M 31.09M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 35.55M 36.43M
Weighted Average Basic & Diluted Shares Outstanding		 27.10M 27.32M 27.36M 27.43M 27.59M 27.62M 27.83M 28.12M 34.48M 34.74M 35.07M

Annual Cash Flow Statements for Adherex Technologies

This table details how cash moves in and out of Adherex Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -1.37 2.98 24 -5.48 -9.13 17 -9.24 2.67 -11 13 10
Net Cash From Operating Activities		 -1.86 -2.12 -3.64 -7.83 -9.06 -16 -14 -18 -17 27 -12
Net Cash From Continuing Operating Activities		 -1.86 -2.12 -3.64 -7.83 -9.06 -16 -14 -18 -17 27 -12
Net Income / (Loss) Continuing Operations		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Consolidated Net Income / (Loss)		 -0.66 -2.79 -7.05 -9.89 -13 -18 -17 -24 -16 -0.44 -9.74
Amortization Expense		 - - - 0.00 0.06 0.40 0.02 0.15 0.29 0.96 0.17
Non-Cash Adjustments To Reconcile Net Income		 0.10 0.70 2.26 2.10 3.08 2.78 4.04 4.40 5.39 9.51 12
Changes in Operating Assets and Liabilities, net		 -1.30 -0.04 1.15 -0.04 0.57 -0.66 -0.93 1.10 -6.78 17 -15
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities		 0.50 5.11 28 2.35 -0.07 32 4.98 21 6.64 -14 23
Net Cash From Continuing Financing Activities		 0.50 5.11 28 2.35 -0.07 32 4.99 21 6.64 -14 23
Repayment of Debt		 - - - - - 0.00 0.00 -4.94 0.00 -15 -21
Other Financing Activities, net		 0.50 0.11 0.59 2.35 0.00 0.46 0.03 0.73 1.64 1.13 44
Cash Interest Paid		 - - - - - - - - - 3.82 4.16
Cash Income Taxes Paid		 - - - - - - - - - 0.00 0.75

Quarterly Cash Flow Statements for Adherex Technologies

This table details how cash moves in and out of Adherex Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 0.87 38 -8.13 -2.73 -14 -3.96 -3.97 3.24 15 3.39 1.07
Net Cash From Operating Activities		 -4.86 39 -8.39 -2.21 -1.47 -4.32 -3.69 1.49 -5.96 2.38 0.05
Net Cash From Continuing Operating Activities		 -4.86 39 -8.39 -2.21 -1.47 -4.32 -3.69 1.49 -5.96 2.38 0.05
Net Income / (Loss) Continuing Operations		 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20 1.97
Consolidated Net Income / (Loss)		 -2.68 13 -5.55 -5.74 -1.99 -1.17 -3.15 -0.64 -4.79 0.20 1.97
Amortization Expense		 0.07 0.74 0.05 0.05 -0.68 0.04 -0.01 0.01 0.13 0.03 0.03
Non-Cash Adjustments To Reconcile Net Income		 0.18 1.60 1.33 6.25 1.14 0.88 2.69 0.57 7.79 0.94 1.49
Changes in Operating Assets and Liabilities, net		 -2.42 24 -4.21 -2.76 0.05 -4.07 -3.21 1.55 -9.10 1.22 -3.44
Net Cash From Financing Activities		 5.73 -1.13 0.26 -0.53 -12 0.36 -0.28 1.75 21 1.01 1.02
Net Cash From Continuing Financing Activities		 5.73 -1.13 0.26 -0.53 -12 0.36 -0.28 1.75 21 1.01 1.02
Other Financing Activities, net		 0.73 0.61 0.26 -0.53 0.79 0.36 -0.28 1.75 42 1.01 1.02

Annual Balance Sheets for Adherex Technologies

This table presents Adherex Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1.02 3.97 28 23 14 31 22 27 27 45 71
Total Current Assets		 1.02 3.97 28 23 14 31 22 27 27 44 67
Cash & Equivalents		 0.94 3.93 28 23 14 30 21 24 13 27 37
Accounts Receivable		 - - - - - - - 1.55 8.81 13 23
Inventories, net		 - - - - - - 0.00 0.58 2.16 1.06 1.57
Prepaid Expenses		 0.08 0.04 0.13 0.17 0.23 0.80 1.03 0.77 2.58 3.08 3.74
Other Current Assets		 0.00 0.00 0.01 0.00 0.01 0.28 0.25 0.06 0.04 0.47 1.73
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.00 0.00 0.00 0.00 0.26 0.00 0.00 0.21 0.01 0.82 3.51
Noncurrent Note & Lease Receivables		 - - - - - - - - - 0.00 2.79
Other Noncurrent Operating Assets		 - - - 0.00 0.26 - - 0.21 0.01 0.82 0.72
Total Liabilities & Shareholders' Equity		 1.02 3.97 28 23 14 31 22 27 27 45 71
Total Liabilities		 0.47 0.40 1.64 1.64 2.27 2.35 6.64 30 38 51 35
Total Current Liabilities		 0.47 0.40 1.64 1.64 2.27 2.35 1.65 4.61 7.55 6.92 11
Accounts Payable		 0.30 0.24 0.86 1.03 1.61 1.57 0.78 2.39 3.78 3.24 4.64
Accrued Expenses		 0.09 0.13 0.62 0.61 0.66 0.78 0.88 2.22 3.75 3.43 5.64
Other Current Liabilities		 0.08 0.03 0.17 - - - - 0.00 0.02 0.00 0.25
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 0.00 0.00 4.99 25 31 44 25
Other Noncurrent Operating Liabilities		 - - - - - 0.00 - 25 31 19 25
Total Equity & Noncontrolling Interests		 0.55 3.57 27 21 12 29 16 -2.57 -12 -5.87 35
Total Preferred & Common Equity		 0.55 3.57 27 21 12 29 16 -2.57 -12 -5.87 35
Total Common Equity		 0.55 3.57 27 21 12 29 16 -2.57 -12 -5.87 35
Common Stock		 111 117 147 151 155 190 194 199 206 213 264
Retained Earnings		 -112 -114 -121 -131 -144 -162 -179 -203 -219 -220 -229
Accumulated Other Comprehensive Income / (Loss)		 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24

Quarterly Balance Sheets for Adherex Technologies

This table presents Adherex Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 19 69 63 59 46 45 49 72 76
Total Current Assets		 19 68 62 58 43 41 46 67 73
Cash & Equivalents		 12 51 43 40 23 19 22 40 41
Accounts Receivable		 4.53 10 12 13 15 18 19 19 23
Inventories, net		 1.76 2.06 2.14 1.13 1.40 2.20 2.48 1.86 2.37
Prepaid Expenses		 0.25 4.49 4.38 3.07 2.44 1.42 1.40 3.46 3.64
Other Current Assets		 0.02 0.16 0.28 0.55 1.00 0.97 0.90 2.62 1.98
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 0.08 1.02 0.99 0.96 3.43 4.08 3.20 4.94 3.25
Noncurrent Note & Lease Receivables		 - - - - 2.63 3.31 2.45 4.25 2.59
Other Noncurrent Operating Assets		 0.08 1.02 0.99 0.96 0.79 0.77 0.74 0.69 0.67
Total Liabilities & Shareholders' Equity		 19 69 63 59 46 45 49 72 76
Total Liabilities		 30 66 65 64 52 52 54 34 33
Total Current Liabilities		 3.91 9.84 7.75 7.44 8.37 8.41 9.82 9.59 12
Accounts Payable		 2.94 5.20 4.45 3.87 5.28 5.94 5.87 6.28 5.52
Accrued Expenses		 0.95 4.36 3.04 3.31 2.84 2.23 3.70 3.06 3.70
Other Current Liabilities		 0.02 0.02 0.01 0.01 0.00 0.00 0.00 0.25 3.18
Total Noncurrent Liabilities		 26 56 57 57 44 44 44 25 21
Other Noncurrent Operating Liabilities		 26 32 32 32 19 19 19 25 21
Total Equity & Noncontrolling Interests		 -11 3.01 -1.36 -5.17 -5.88 -7.46 -4.49 38 42
Total Preferred & Common Equity		 -11 3.01 -1.36 -5.17 -5.88 -7.46 -4.49 38 42
Total Common Equity		 -11 3.01 -1.36 -5.17 -5.88 -7.46 -4.49 38 42
Common Stock		 205 208 209 211 214 215 219 266 268
Retained Earnings		 -217 -206 -212 -218 -221 -224 -225 -229 -227
Accumulated Other Comprehensive Income / (Loss)		 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24 1.24

Annual Metrics And Ratios for Adherex Technologies

This table displays calculated financial ratios and metrics derived from Adherex Technologies' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 10,939,226.00 13,642,567.00 15,869,978.00 19,729,164.00 19,895,830.00 25,809,684.00 26,006,853.00 26,237,726.00 26,634,676.00 - 28,116,829.00
DEI Adjusted Shares Outstanding		 10,939,226.00 13,642,567.00 15,869,978.00 19,729,164.00 19,895,830.00 25,809,684.00 26,006,853.00 26,237,726.00 26,634,676.00 - 28,116,829.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.06 -0.20 -0.44 -0.50 -0.64 -0.70 -0.67 -0.90 -0.60 - -0.35
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -100.00% 0.00% 1,284.50% 123.69% -6.09%
EBITDA Growth		 69.61% -322.51% -153.59% -44.31% -27.26% -33.45% 0.81% -30.20% 44.24% 120.48% -280.98%
EBIT Growth		 69.61% -322.51% -153.59% -44.31% -27.88% -35.87% 2.96% -30.94% 43.34% 118.78% -360.12%
NOPAT Growth		 34.31% -51.90% -142.11% -49.75% -24.98% -37.48% 3.70% -31.16% 43.46% 120.11% -344.63%
Net Income Growth		 69.72% -323.22% -152.64% -40.33% -29.20% -41.75% 4.21% -36.71% 32.34% 97.28% -2,134.17%
EPS Growth		 72.73% -266.67% -113.64% -10.64% -23.08% -18.75% 11.84% -34.33% 33.33% 96.67% -1,600.00%
Operating Cash Flow Growth		 -9.59% -14.07% -71.42% -114.94% -15.77% -72.13% 8.80% -26.97% 5.07% 257.38% -146.23%
Free Cash Flow Firm Growth		 23.70% 21.93% -81.60% -96.88% -20.19% -47.97% 0.44% 181.19% -199.43% 188.52% -485.66%
Invested Capital Growth		 76.74% 9.64% -322.19% 2.33% -20.91% 28.23% 71.19% -7,176.29% 5.71% -29.65% 95.97%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -100.00% 0.00% 62.83% -3.67% 15.09%
EBITDA Q/Q Growth		 -152.29% -27.54% -19.71% -8.32% -4.51% 4.51% -9.71% -7.55% 25.12% -0.16% -13.31%
EBIT Q/Q Growth		 -152.29% -27.54% -19.71% -8.32% -4.64% 4.50% -9.76% -7.81% 24.70% 44.88% -32.21%
NOPAT Q/Q Growth		 37.89% -26.14% -24.53% -6.01% -4.40% 1.69% -5.26% -9.33% 25.26% 52.49% -34.72%
Net Income Q/Q Growth		 -151.93% -27.58% -19.44% -7.55% -5.15% 2.01% -7.36% -11.42% 20.65% 61.52% -40.36%
EPS Q/Q Growth		 -142.86% -22.22% -17.50% 0.00% -88.24% 30.28% -9.84% -9.76% 22.08% 77.78% -78.95%
Operating Cash Flow Q/Q Growth		 2.31% -9.65% -24.18% -25.90% 12.88% -12.19% 0.27% -24.53% 10.18% 14.35% -56.21%
Free Cash Flow Firm Q/Q Growth		 53.19% -26.15% -9.55% -21.25% 13.30% -18.46% -60.05% 160.94% -219.73% -60.86% -59.19%
Invested Capital Q/Q Growth		 -13.54% -12.30% -81.08% 11.83% -645.80% 35.69% 93.12% -957.17% -8.40% 28.59% 95.04%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 0.00% 94.40% 94.08% 93.30% 91.57%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,225.29% 0.00% -1,462.48% -58.90% 5.39% -13.64%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,520.59% 0.00% -1,471.60% -60.09% 5.40% -14.07%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,461.76% 0.00% -1,472.18% -60.25% 5.06% -14.01%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,652.35% 0.00% -1,544.89% -75.50% -0.92% -21.82%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.78% 100.00% 614.08% 101.10%
Interest Burden Percent		 99.55% 99.71% 99.34% 96.60% 97.59% 101.82% 100.51% 104.12% 125.30% -2.95% 154.01%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -113.52% -135.45% -46.47% -41.14% -76.99% -88.46% -77.37% -359.22% 226.13% 4.98% -65.82%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -78.07% 0.00% -91.58% -47.60% 6.70% -10.83%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -79.49% 0.00% -96.10% -59.64% -1.21% -16.87%
Return on Common Equity (ROCE)		 -113.52% -135.45% -46.47% -41.14% -76.99% -88.46% -77.37% -359.22% 226.13% 4.98% -65.82%
Return on Equity Simple (ROE_SIMPLE)		 -120.26% -78.12% -26.33% -46.39% -107.58% -62.29% -109.98% 923.08% 138.06% 7.43% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.32 -2.01 -4.87 -7.29 -9.11 -13 -12 -16 -8.94 1.80 -4.40
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -7,364.41% 0.00% -1,030.12% -42.07% 3.78% -9.85%
Net Nonoperating Expense Percent (NNEP)		 40.87% -32.02% -13.55% -10.19% -20.14% -25.41% -22.76% -39.24% -37.70% -11.08% -16.81%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 75.06% -29.91% -12.40%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.60% 5.92% 6.70% 8.43%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 7,617.65% 0.00% 1,154.53% 96.86% 48.49% 63.38%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 3,002.94% 0.00% 230.03% 0.26% 0.65% 0.56%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 10,620.59% 0.00% 1,565.99% 154.17% 87.90% 105.64%
Earnings before Interest and Taxes (EBIT)		 -0.66 -2.80 -7.09 -10 -13 -18 -17 -23 -13 2.41 -6.26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.66 -2.80 -7.09 -10 -13 -17 -17 -22 -13 2.56 -6.09
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 17.97 3.44 5.94 5.91 10.87 6.61 7.26 0.00 0.00 0.00 6.10
Price to Tangible Book Value (P/TBV)		 17.97 3.44 5.94 5.91 10.87 6.61 7.26 0.00 0.00 0.00 6.10
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 1,131.07 0.00 164.09 14.06 3.65 4.85
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 952.58 0.00 148.37 13.42 3.08 4.03
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 57.18 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 60.96 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 81.55 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.43 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.64 0.00 15.83 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.02 0.02 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.02 0.02 0.00
Financial Leverage		 -2.80 -1.18 -1.06 -1.06 -1.10 -1.07 -1.04 -3.05 2.66 2.31 -2.15
Leverage Ratio		 2.92 1.21 1.07 1.07 1.12 1.11 1.20 3.74 -3.79 -4.10 3.90
Compound Leverage Factor		 2.91 1.21 1.06 1.03 1.09 1.13 1.21 3.89 -4.75 0.12 6.01
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.32% 2.42% 2.31% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.32% 2.42% 2.31% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 87.68% 97.58% 97.69% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 -0.05 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.08 1.08 -10.44 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 -0.05 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -0.08 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.53 1.52 -14.89 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.03 -0.08 0.00
Altman Z-Score		 -142.19 -23.21 52.36 37.77 17.79 41.18 -2.30 -7.16 -6.69 -2.57 0.45
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.16 9.88 17.28 14.02 6.11 13.39 13.54 5.80 3.56 6.38 6.37
Quick Ratio		 2.00 9.77 17.19 13.92 6.01 12.93 12.76 5.49 2.92 5.71 5.71
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2.62 -2.05 -3.72 -7.32 -8.80 -13 -13 11 -10 9.26 -36
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -31.68 -91.29 11.29 -2.84 2.23 -8.58
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -37.94 -100.15 -19.38 -4.66 6.49 -2.99
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -37.94 -100.15 -19.38 -4.66 6.49 -2.99
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.06 0.79 1.32 0.77
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.10 4.38 2.47
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.92 1.98 2.87
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.41 0.91 0.96
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 88.96 83.30 147.60
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 396.02 184.33 127.27
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6,720.67 894.09 402.31 381.87
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -6,720.67 -409.11 -134.68 -107.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.39 -0.36 -1.50 -1.47 -1.78 -1.27 -0.37 -27 -25 -33 -1.32
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 -0.11 0.00 -0.11 -0.82 -1.64 -2.63
Increase / (Decrease) in Invested Capital		 1.30 0.04 -1.15 0.04 -0.31 0.50 0.91 -26 1.53 -7.47 31
Enterprise Value (EV)		 8.90 8.35 131 103 115 162 93 228 285 147 180
Market Capitalization		 9.85 12 159 126 129 192 114 252 299 173 216
Book Value per Share		 $0.05 $0.26 $1.69 $1.08 $0.60 $1.13 $0.61 ($0.10) ($0.44) ($0.21) $1.26
Tangible Book Value per Share		 $0.05 $0.26 $1.69 $1.08 $0.60 $1.13 $0.61 ($0.10) ($0.44) ($0.21) $1.26
Total Capital		 0.55 3.57 27 21 12 29 16 -2.93 -12 -6.01 35
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.36 -0.29 -0.14 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.36 -0.29 -0.14 0.00
Net Debt		 -0.94 -3.93 -28 -23 -14 -30 -21 -24 -14 -27 -37
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.39 -0.36 -1.50 -1.47 -2.04 -1.27 -0.37 -1.66 6.04 11 20
Debt-free Net Working Capital (DFNWC)		 0.55 3.57 27 21 12 29 21 22 19 37 57
Net Working Capital (NWC)		 0.55 3.57 27 21 12 29 21 22 19 37 57
Net Nonoperating Expense (NNE)		 -0.66 0.78 2.18 2.60 3.67 5.59 5.29 7.90 7.11 2.23 5.34
Net Nonoperating Obligations (NNO)		 -0.94 -3.93 -28 -23 -14 -30 -16 -24 -14 -27 -37
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.06 0.40 0.02 0.15 0.29 0.16 0.17
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% -749.41% 0.00% -107.82% 28.40% 22.24% 44.21%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 17,100.00% 0.00% 1,440.98% 90.84% 78.26% 126.62%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 17,100.00% 0.00% 1,440.98% 90.84% 78.26% 126.62%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.06) ($0.22) ($0.47) $0.00 ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Adjusted Weighted Average Basic Shares Outstanding		 10.94M 13.64M 18.46M 0.00 19.90M 26.00M 26.01M 26.28M 26.57M 27.29M 28.58M
Adjusted Diluted Earnings per Share		 ($0.06) ($0.22) ($0.47) $0.00 ($0.64) ($0.76) ($0.67) ($0.90) ($0.60) ($0.02) ($0.34)
Adjusted Weighted Average Diluted Shares Outstanding		 10.94M 13.64M 18.46M 0.00 19.90M 26.00M 26.01M 26.28M 26.57M 27.29M 28.58M
Adjusted Basic & Diluted Earnings per Share		 ($0.06) ($0.22) ($0.47) ($0.52) ($0.64) ($0.76) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.83M 12.77M 15.01M 18.94M 19.90M 23.70M 26.01M 26.41M 27.10M 27.59M 34.48M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.32 -2.01 -4.87 -7.29 -9.11 -13 -12 -16 -8.94 1.80 -4.40
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -7,364.41% 0.00% -1,030.12% -42.07% 3.78% -9.85%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -10,652.35% 0.00% -1,532.90% -75.50% -0.15% -21.58%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -43.27 -121.54 -24.25 -3.48 0.58 -1.50
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -30.46 -84.90 -16.97 -2.43 0.43 -1.06
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -43.27 -121.54 -24.25 -3.48 0.58 -1.50
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -30.46 -84.90 -16.97 -2.43 0.43 -1.06
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% -0.56% -0.77% -0.24% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Adherex Technologies

This table displays calculated financial ratios and metrics derived from Adherex Technologies' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 26,634,676.00 27,099,908.00 27,322,141.00 27,364,335.00 - 27,594,008.00 27,618,743.00 27,831,698.00 28,116,829.00 34,475,178.00 34,737,030.00
DEI Adjusted Shares Outstanding		 26,634,676.00 27,099,908.00 27,322,141.00 27,364,335.00 - 27,594,008.00 27,618,743.00 27,831,698.00 28,116,829.00 34,475,178.00 34,737,030.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.10 0.47 -0.20 -0.21 - -0.04 -0.11 -0.02 -0.17 0.01 0.06
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 534.20% 1,413.24% 118.41% 7.05% -18.59% -65.52% 32.91% 78.69% 73.84% 72.64% 85.18%
EBITDA Growth		 70.68% 373.89% -10.38% -432.40% 2.01% -105.24% 45.50% 96.51% -167.03% 86.13% 165.57%
EBIT Growth		 69.86% 358.82% -8.47% -400.00% 43.27% -105.81% 46.28% 96.31% -148.25% 83.54% 163.73%
NOPAT Growth		 70.37% 472.54% -7.99% -411.50% 48.62% -104.12% 45.78% 96.37% -173.34% 85.27% 188.94%
Net Income Growth		 60.89% 312.11% -2.00% -207.18% 25.99% -109.08% 43.24% 88.88% -141.11% 117.25% 162.60%
EPS Growth		 65.38% 278.26% 4.76% -200.00% 77.78% -109.76% 45.00% 90.48% -750.00% 125.00% 145.45%
Operating Cash Flow Growth		 28.55% 800.14% -112.54% 20.07% 69.67% -111.06% 56.05% 167.68% -304.48% 155.10% 101.36%
Free Cash Flow Firm Growth		 -112.69% 3,050.62% 981.84% -5.71% 343.50% -134.01% -149.33% -202.45% -586.13% -29.22% -27.03%
Invested Capital Growth		 5.71% -1,892.51% 0.00% -96.82% -29.65% 40.79% 41.15% 41.95% 95.97% 91.27% 104.54%
Revenue Q/Q Growth		 49.42% 160.68% -71.38% -3.97% 13.64% 10.42% 10.30% 29.11% 10.55% 9.66% 18.31%
EBITDA Q/Q Growth		 -79.77% 928.76% -134.68% -3.04% 66.91% 16.54% -260.50% 93.40% -1,245.56% 95.66% 1,772.38%
EBIT Q/Q Growth		 -74.06% 855.74% -136.92% -2.95% 80.25% 22.57% -241.21% 92.93% -1,229.17% 94.87% 1,421.37%
NOPAT Q/Q Growth		 -78.76% 1,179.92% -125.67% -3.23% 82.05% 13.49% -238.12% 93.08% -1,250.79% 95.34% 2,141.77%
Net Income Q/Q Growth		 -43.65% 578.64% -143.26% -3.28% 65.39% 41.31% -170.56% 79.76% -650.16% 104.20% 881.59%
EPS Q/Q Growth		 -28.57% 555.56% -148.78% -5.00% 90.48% -100.00% -175.00% 81.82% -750.00% 105.88% 400.00%
Operating Cash Flow Q/Q Growth		 -76.09% 903.44% -121.48% 73.70% 33.18% -192.94% 14.64% 140.50% -499.33% 139.90% -97.90%
Free Cash Flow Firm Q/Q Growth		 -113.99% 2,235.76% -31.16% -54.17% -63.86% -398.33% 0.16% 4.82% -71.49% 20.70% 1.85%
Invested Capital Q/Q Growth		 -8.40% -92.37% 7.80% -2.37% 28.59% 12.14% 8.37% -0.98% 95.04% -90.27% 147.64%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 92.96% 97.83% 91.63% 80.54% 91.56% 95.74% 89.98% 94.70% 87.20% 96.23% 95.97%
EBITDA Margin		 -17.89% 56.89% -68.95% -73.97% -21.54% -8.65% -28.27% -1.44% -17.58% -0.70% 9.82%
Operating Margin		 -18.67% 54.16% -69.39% -74.59% -11.79% -9.23% -28.31% -1.52% -18.53% -0.79% 9.72%
EBIT Margin		 -18.61% 53.96% -69.62% -74.63% -12.97% -9.10% -28.14% -1.54% -18.52% -0.87% 9.68%
Profit (Net Income) Margin		 -27.55% 50.59% -76.47% -82.23% -25.05% -13.31% -32.66% -5.12% -34.74% 1.33% 11.04%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 122.53% 0.00% 100.00% 100.00% 102.27% 0.00% 97.92%
Interest Burden Percent		 148.01% 93.74% 109.83% 110.18% 157.59% 0.00% 116.05% 332.29% 183.39% 0.00% 116.41%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.08%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 226.13% -131.51% -201.55% 14.43% 4.98% 1,007.54% 272.95% 143.64% -65.82% -52.68% -18.58%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2,368.89%
Operating Return on Assets (OROA)		 -14.70% 53.30% -53.89% -94.50% -17.17% -4.86% -17.35% -1.10% -14.32% -0.75% 9.51%
Return on Assets (ROA)		 -21.76% 49.97% -59.19% -104.12% -33.16% -7.12% -20.13% -3.67% -26.85% 1.15% 10.84%
Return on Common Equity (ROCE)		 226.13% -131.51% -201.55% 14.43% 4.98% 1,007.54% 272.95% 143.64% -65.82% -52.68% -18.58%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 94.36% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.27 14 -3.53 -3.64 -0.65 -0.57 -1.91 -0.13 -1.79 -0.08 1.70
NOPAT Margin		 -13.07% 54.16% -48.57% -52.21% -8.25% -6.46% -19.81% -1.06% -12.97% -0.55% 9.52%
Net Nonoperating Expense Percent (NNEP)		 -7.48% -3.89% -9.36% -7.86% -6.60% -1.61% -3.99% -1.62% -9.44% 0.90% 0.91%
Return On Investment Capital (ROIC_SIMPLE)		 10.69% 500.47% 219.91% 67.46% 10.88% 9.42% 25.24% 2.88% -5.04% -0.22% 4.01%
Cost of Revenue to Revenue		 7.04% 2.17% 8.37% 19.46% 8.44% 4.26% 10.02% 5.30% 12.80% 3.77% 4.03%
SG&A Expenses to Revenue		 71.58% 23.14% 94.52% 87.77% 52.95% 67.02% 72.07% 54.18% 61.27% 21.09% 25.95%
R&D to Revenue		 0.33% 0.01% 2.16% 1.39% 0.63% 1.07% 1.11% 0.23% 0.15% 0.32% 0.66%
Operating Expenses to Revenue		 111.64% 43.68% 161.02% 155.13% 103.34% 104.97% 118.29% 96.22% 105.73% 97.01% 86.25%
Earnings before Interest and Taxes (EBIT)		 -1.81 14 -5.06 -5.21 -1.03 -0.80 -2.72 -0.19 -2.55 -0.13 1.73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.74 14 -5.01 -5.16 -1.71 -0.76 -2.73 -0.18 -2.42 -0.11 1.76
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 99.98 0.00 0.00 0.00 0.00 0.00 0.00 6.10 5.63 8.80
Price to Tangible Book Value (P/TBV)		 0.00 99.98 0.00 0.00 0.00 0.00 0.00 0.00 6.10 5.63 8.80
Price to Revenue (P/Rev)		 14.06 6.70 3.41 2.77 3.65 5.44 6.88 6.72 4.85 4.16 6.31
Price to Earnings (P/E)		 0.00 105.96 61.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.94% 1.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 278.44
Enterprise Value to Revenue (EV/Rev)		 13.42 5.56 2.53 1.95 3.08 4.70 6.32 6.15 4.03 3.37 5.61
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 34.76 18.40 38.07 57.18 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 40.44 21.37 59.39 60.96 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 40.04 21.07 81.67 81.55 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 9.09 5.37 4.08 5.43 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 4.78 2.45 4.07 15.83 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.02 -0.09 0.18 0.04 0.02 0.02 0.02 0.02 0.00 0.00 0.00
Long-Term Debt to Equity		 0.02 -0.09 0.18 0.04 0.02 0.02 0.02 0.02 0.00 0.00 0.00
Financial Leverage		 2.66 10.76 31.91 3.39 2.31 25.91 7.04 6.48 -2.15 -1.98 -1.72
Leverage Ratio		 -3.79 -21.04 -46.54 -4.96 -4.10 -40.33 -12.25 -11.20 3.90 3.72 3.45
Compound Leverage Factor		 -5.61 -19.73 -51.12 -5.47 -6.47 0.00 -14.22 -37.20 7.16 0.00 4.01
Debt to Total Capital		 2.42% -9.76% 15.40% 4.21% 2.31% 2.10% 1.49% 2.18% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 2.42% -9.76% 15.40% 4.21% 2.31% 2.10% 1.49% 2.18% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 97.58% 109.76% 84.60% 95.79% 97.69% 97.90% 98.51% 97.82% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.02 -0.04 -0.04 -0.09 -0.05 0.01 0.01 0.02 0.00 0.00 0.00
Net Debt to EBITDA		 1.08 -7.16 -6.44 -16.03 -10.44 1.93 1.82 4.10 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.02 -0.04 -0.04 -0.09 -0.05 0.01 0.01 0.02 0.00 0.00 0.00
Debt to NOPAT		 0.03 -0.04 -0.04 -0.19 -0.08 0.02 0.02 0.03 0.00 0.00 0.00
Net Debt to NOPAT		 1.52 -8.24 -7.38 -34.40 -14.89 2.72 2.78 6.75 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.03 -0.04 -0.04 -0.19 -0.08 0.02 0.02 0.03 0.00 0.00 0.00
Altman Z-Score		 -5.34 0.87 -1.60 -2.32 -2.82 -3.23 -2.95 -1.82 0.63 0.92 4.34
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.56 6.93 8.02 7.80 6.38 5.13 4.85 4.69 6.37 6.98 5.85
Quick Ratio		 2.92 6.25 7.14 7.16 5.71 4.55 4.30 4.21 5.71 6.15 5.21
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -2.80 60 41 19 6.81 -20 -20 -19 -33 -26 -26
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -2.31 56.69 38.55 18.02 3.88 -33.59 -33.43 -32.29 -14.06 -3,751.47 -8,591.07
Operating Cash Flow to Interest Expense		 -4.02 37.05 -7.86 -2.11 -0.84 -7.14 -6.07 2.50 -2.53 339.86 16.67
Operating Cash Flow Less CapEx to Interest Expense		 -4.02 37.05 -7.86 -2.11 -0.84 -7.14 -6.07 2.50 -2.53 339.86 16.67
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.79 0.99 0.77 1.27 1.32 0.53 0.62 0.72 0.77 0.86 0.98
Accounts Receivable Turnover		 4.10 0.00 3.97 5.66 4.38 2.40 2.23 2.41 2.47 2.98 2.91
Inventory Turnover		 0.92 1.15 1.01 2.22 1.98 1.73 1.55 1.48 2.87 2.43 1.62
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.41 0.42 0.49 0.94 0.91 0.57 0.65 0.55 0.96 0.69 0.65
Days Sales Outstanding (DSO)		 88.96 0.00 91.92 64.47 83.30 151.86 163.39 151.74 147.60 122.42 125.63
Days Inventory Outstanding (DIO)		 396.02 317.51 359.96 164.25 184.33 210.48 235.58 246.30 127.27 150.20 224.75
Days Payable Outstanding (DPO)		 894.09 867.89 746.62 388.27 402.31 636.29 563.22 665.52 381.87 532.66 562.83
Cash Conversion Cycle (CCC)		 -409.11 -550.37 -294.74 -159.55 -134.68 -273.95 -164.26 -267.49 -107.00 -260.04 -212.45
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -25 -48 -45 -46 -33 -29 -26 -27 -1.32 -2.50 1.19
Invested Capital Turnover		 -0.82 -1.77 -2.19 -1.43 -1.64 -0.80 -0.94 -1.07 -2.63 -3.27 -4.72
Increase / (Decrease) in Invested Capital		 1.53 -46 -45 -22 -7.47 20 18 19 31 26 27
Enterprise Value (EV)		 285 250 124 96 147 145 210 238 180 172 332
Market Capitalization		 299 301 167 137 173 168 229 261 216 212 373
Book Value per Share		 ($0.44) $0.11 ($0.05) ($0.19) ($0.21) ($0.21) ($0.27) ($0.16) $1.26 $1.09 $1.22
Tangible Book Value per Share		 ($0.44) $0.11 ($0.05) ($0.19) ($0.21) ($0.21) ($0.27) ($0.16) $1.26 $1.09 $1.22
Total Capital		 -12 2.75 -1.60 -5.40 -6.01 -6.01 -7.58 -4.59 35 38 42
Total Debt		 -0.29 -0.27 -0.25 -0.23 -0.14 -0.13 -0.11 -0.10 0.00 0.00 0.00
Total Long-Term Debt		 -0.29 -0.27 -0.25 -0.23 -0.14 -0.13 -0.11 -0.10 0.00 0.00 0.00
Net Debt		 -14 -51 -43 -41 -27 -23 -19 -22 -37 -40 -41
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 6.04 7.15 11 10 11 12 14 14 20 17 19
Debt-free Net Working Capital (DFNWC)		 19 58 54 51 37 35 32 36 57 57 60
Net Working Capital (NWC)		 19 58 54 51 37 35 32 36 57 57 60
Net Nonoperating Expense (NNE)		 1.41 0.91 2.03 2.09 1.33 0.60 1.24 0.51 3.00 -0.28 -0.27
Net Nonoperating Obligations (NNO)		 -14 -51 -43 -41 -27 -23 -19 -22 -37 -40 -41
Total Depreciation and Amortization (D&A)		 0.07 0.74 0.05 0.05 -0.68 0.04 -0.01 0.01 0.13 0.03 0.03
Debt-free, Cash-free Net Working Capital to Revenue		 28.40% 15.91% 23.25% 20.69% 22.24% 38.59% 41.06% 36.87% 44.21% 33.56% 31.84%
Debt-free Net Working Capital to Revenue		 90.84% 129.77% 111.32% 102.40% 78.26% 111.94% 97.23% 93.45% 126.62% 112.34% 101.49%
Net Working Capital to Revenue		 90.84% 129.77% 111.32% 102.40% 78.26% 111.94% 97.23% 93.45% 126.62% 112.34% 101.49%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.09) $0.41 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01 $0.06
Adjusted Weighted Average Basic Shares Outstanding		 26.57M 27.05M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 34.34M 34.55M
Adjusted Diluted Earnings per Share		 ($0.09) $0.41 ($0.20) ($0.21) ($0.02) ($0.04) ($0.11) ($0.02) ($0.17) $0.01 $0.05
Adjusted Weighted Average Diluted Shares Outstanding		 26.57M 31.09M 27.30M 27.37M 27.29M 27.58M 27.66M 27.89M 28.58M 35.55M 36.43M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.10M 27.32M 27.36M 27.43M 27.59M 27.62M 27.83M 28.12M 34.48M 34.74M 35.07M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.27 9.62 -3.53 -3.64 -0.65 -0.57 -1.91 -0.13 -1.79 -0.08 1.70
Normalized NOPAT Margin		 -13.07% 37.91% -48.57% -52.21% -8.25% -6.46% -19.81% -1.06% -12.97% -0.55% 9.52%
Pre Tax Income Margin		 -27.55% 50.59% -76.47% -82.23% -20.44% 0.00% -32.66% -5.12% -33.97% 0.00% 11.27%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.50 12.99 -4.74 -4.98 -0.58 -1.32 -4.47 -0.32 -1.08 -18.71 577.00
NOPAT to Interest Expense		 -1.05 13.04 -3.31 -3.48 -0.37 -0.93 -3.15 -0.22 -0.76 -11.90 566.93
EBIT Less CapEx to Interest Expense		 -1.50 12.99 -4.74 -4.98 -0.58 -1.32 -4.47 -0.32 -1.08 -18.71 577.00
NOPAT Less CapEx to Interest Expense		 -1.05 13.04 -3.31 -3.48 -0.37 -0.93 -3.15 -0.22 -0.76 -11.90 566.93
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Fennec Pharmaceuticals’ second-quarter 2026 results show a significant improvement in operating performance. The company reported revenue of $17.9 million, up 18% from $15.1 million in the first quarter and 85% from the restated $9.7 million reported in the second quarter of 2025. Gross profit increased to $17.2 million, producing a gross margin of approximately 96%, compared with about 90% a year earlier.

Operating income turned positive at $1.7 million, compared with an operating loss of $119,000 in Q1 2026 and $2.7 million in Q2 2025. Net income improved to $2.0 million, or $0.06 per basic share, versus $201,000 in the prior quarter and a $3.2 million loss in the year-earlier quarter. This represents the company’s second consecutive quarterly profit after reporting losses throughout the comparable 2025 and 2024 periods, aside from the previously reported Q1 2026 profit.

  • Revenue growth is accelerating. Quarterly revenue has risen from $6.5 million in Q3 2023 and $7.9 million in Q4 2024 to $17.9 million in Q2 2026, although quarterly comparisons can be affected by product timing.
  • Profitability has materially improved. Fennec moved from a $4.8 million net loss in Q4 2025 to a $201,000 profit in Q1 2026 and a $2.0 million profit in Q2 2026. Operating income also turned positive in the latest quarter.
  • The company has a strong liquidity position. Cash and equivalents increased to $41.2 million at June 30, 2026, from $18.7 million a year earlier. Total current assets of $72.5 million were nearly six times current liabilities of $12.4 million.
  • Balance-sheet equity has recovered. Total equity improved to $42.4 million in Q2 2026 from negative equity of $7.5 million in Q2 2025 and negative equity of $4.5 million in Q3 2025. The improvement reflects higher common stock balances and the return to profitability.
  • Operating cash flow has improved over the longer trend. Cash flow from operations was positive in Q3 2025, Q1 2026 and Q2 2026, compared with negative operating cash flow in Q2 and Q4 2024 and Q1 and Q2 2025.
  • Cash generation remains modest relative to reported earnings. Q2 2026 operating cash flow was only $50,000 despite $2.0 million of net income, largely because changes in operating assets and liabilities used $3.4 million of cash.
  • Accounts receivable are rising with sales. Receivables increased to $23.3 million from $18.8 million in Q1 2026 and $17.5 million in Q2 2025. This may reflect growth, but investors should monitor collections and working-capital conversion.
  • Marketing spending remains very high. Marketing expense was $10.7 million in Q2 2026, or roughly 60% of revenue. Selling, general and administrative expense added another $4.6 million, leaving limited room for weaker sales or higher promotional costs.
  • Profitability is not yet established over the full period. The company continues to carry accumulated retained losses of $227.2 million, and its recent earnings improvement follows substantial losses in 2024 and 2025.
  • Financing still contributed to recent cash growth. The company generated $1.0 million from financing activities in Q2 2026, while Q4 2025 cash generation was heavily influenced by $20.8 million of financing activity. Continued reliance on financing or equity issuance could create dilution risk.

Overall, the statements indicate a meaningful turnaround: revenue is expanding, margins are high, profitability has emerged, and the balance sheet is considerably stronger than it was in 2024 and much of 2025. The main questions for investors are whether sales growth can continue, whether marketing costs can decline as a percentage of revenue, and whether accounting earnings can translate into consistent operating cash flow.

10/14/26 06:50 AM ETAI Generated. May Contain Errors.

Adherex Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Adherex Technologies' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Adherex Technologies' net income appears to be on a downward trend, with a most recent value of -$9.74 million in 2025, falling from -$659 thousand in 2015. The previous period was -$436 thousand in 2024. See Adherex Technologies' forecast for analyst expectations on what's next for the company.

Adherex Technologies' total operating income in 2025 was -$6.28 million, based on the following breakdown:
  • Total Gross Profit: $40.88 million
  • Total Operating Expenses: $47.16 million

Over the last 10 years, Adherex Technologies' total revenue changed from $0.00 in 2015 to $44.64 million in 2025, a change of 4,464,200,000.0%.

In the past 11 quarters, Adherex Technologies' cash and equivalents has ranged from $12.40 million in Q3 2023 to $51.18 million in Q1 2024, and is currently $41.25 million as of their latest financial filing in Q2 2026.

Adherex Technologies had total debt of $0.00 at the end of 2025, compared with -$139 thousand in 2024, and none in 2015.

Over the last 10 years, Adherex Technologies' book value per share changed from 0.05 in 2015 to 1.26 in 2025, a change of 2,418.2%.


Related Companies

Financial statements for NASDAQ:FENC last updated on 8/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
This AI fund posted a 34 percent annualized payout last month
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...
Weiss Ratings | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...
Decentralized Masters | Sponsoredtc pixel
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
Why Some AI Stocks Already Surged Over 300 Percent
Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...
Brownstone Research | Sponsoredtc pixel